Insights

Strategic Market Expansion Rosemont Pharmaceuticals has recently invested in assets and acquired a Contract Development Manufacturer Organisation in Greece, indicating a strategic focus on expanding manufacturing capacity and strengthening its presence in the European market for innovative liquid medicines.

Product Innovation & Licensing The company's launch of a licensed liquid omeprazole powder for oral suspension and efforts to convert ‘specials’ into licensed products highlight opportunities to introduce new, patient-focused liquid formulations to healthcare providers and pharmacies.

Regional Collaborations Partnerships such as the collaboration with Kuwait Saudi Pharmaceuticals Industries Company demonstrate Rosemont’s interest in expanding access to liquid medications in the MENA region, presenting opportunities for sales growth through regional distribution channels.

Focus on Swallowing Difficulties With a dedicated portfolio of over 130 liquid medicines and an emphasis on supporting patients with swallowing challenges, Rosemont offers tailored product solutions that could expand into new therapeutic areas or patient segments with similar needs.

Digital & Educational Initiatives Rosemont’s engagement in educational initiatives and use of technology tools suggests openness to developing digital health solutions or training programs that could improve medication adherence and healthcare professional engagement, creating additional sales avenues.

Rosemont Pharmaceuticals Tech Stack

Rosemont Pharmaceuticals uses 8 technology products and services including GDPR, Anaplan, Microsoft Excel, and more. Explore Rosemont Pharmaceuticals's tech stack below.

  • GDPR
    Certificates
  • Anaplan
    Corporate Performance Management
  • Microsoft Excel
    Editors
  • Priority Hints
    Performance
  • Microsoft Project
    Project Management
  • Google Analytics
    Web Analytics
  • Adobe Fonts
    Web Fonts
  • prettyPhoto
    Web Tools And Plugins

Media & News

Rosemont Pharmaceuticals's Email Address Formats

Rosemont Pharmaceuticals uses at least 1 format(s):
Rosemont Pharmaceuticals Email FormatsExamplePercentage
First.Last@rosemontpharma.comJohn.Doe@rosemontpharma.com
92%
F.Last@rosemontpharma.comJ.Doe@rosemontpharma.com
6%
Last@rosemontpharma.comDoe@rosemontpharma.com
1%
FLast@rosemontpharma.comJDoe@rosemontpharma.com
1%

Frequently Asked Questions

Where is Rosemont Pharmaceuticals's headquarters located?

Minus sign iconPlus sign icon
Rosemont Pharmaceuticals's main headquarters is located at Braithwaite Street Leeds, England United Kingdom. The company has employees across 3 continents, including EuropeNorth AmericaAsia.

What is Rosemont Pharmaceuticals's official website and social media links?

Minus sign iconPlus sign icon
Rosemont Pharmaceuticals's official website is rosemontpharma.com and has social profiles on LinkedIn.

What is Rosemont Pharmaceuticals's NAICS code?

Minus sign iconPlus sign icon
Rosemont Pharmaceuticals's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Rosemont Pharmaceuticals have currently?

Minus sign iconPlus sign icon
As of April 2026, Rosemont Pharmaceuticals has approximately 286 employees across 3 continents, including EuropeNorth AmericaAsia. Key team members include Chief Executive Officer: A. S.Chief People Officer: C. H.Chief Scientific Officer: E. C.. Explore Rosemont Pharmaceuticals's employee directory with LeadIQ.

What industry does Rosemont Pharmaceuticals belong to?

Minus sign iconPlus sign icon
Rosemont Pharmaceuticals operates in the Pharmaceutical Manufacturing industry.

What technology does Rosemont Pharmaceuticals use?

Minus sign iconPlus sign icon
Rosemont Pharmaceuticals's tech stack includes GDPRAnaplanMicrosoft ExcelPriority HintsMicrosoft ProjectGoogle AnalyticsAdobe FontsprettyPhoto.

What is Rosemont Pharmaceuticals's email format?

Minus sign iconPlus sign icon
Rosemont Pharmaceuticals's email format typically follows the pattern of First.Last@rosemontpharma.com. Find more Rosemont Pharmaceuticals email formats with LeadIQ.

Rosemont Pharmaceuticals

Pharmaceutical ManufacturingEngland, United Kingdom201-500 Employees

At Rosemont our mission is to be a rapid developer, reliable manufacturer and global supplier of novel-delivery, patient-focused medicines.

Our ambition has always been to support both patients with swallowing difficulties and the healthcare professionals who care for them. We are highly respected in the industry and have been instrumental in establishing best practice for the care of patients with swallowing difficulties. Rosemont advocate the use of liquid medication over manipulating solid dose medications and we have a range of educational materials designed for healthcare professionals which focuses on key patient groups and their medication management challenges.  

At Rosemont we have a portfolio of over 130 oral liquid medicines across a range of therapeutic areas including 70 licensed products. All of our products, both licensed and ‘specials’ are made to the same exacting standards under GMP. Our UK range also includes 9 products licensed for use with PEG/NG tubes. We are always seeking to expand our range of medicines and covert our ‘specials’ to licensed product wherever possible.

Section iconCompany Overview

Headquarters
Braithwaite Street Leeds, England United Kingdom
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
201-500

Section iconFunding & Financials

  • $10M$25M

    Rosemont Pharmaceuticals's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $10M$25M

    Rosemont Pharmaceuticals's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.